Estrogen and Evidence

Colleagues and I conducted a careful analysis of data reported in a methodologically robust clinical trial and published in a prestigious journal to reach this conclusion: failure to take estrogen over the past decade has resulted in tens of thousands of premature deaths among women in the U.S. who have undergone hysterectomy. Estrogen significantly lowers the mortality rate among younger women in this group.

Perhaps it is inevitable when you assert that tens of thousands of women have needlessly lost a decade or two of life, and that the death toll is on-going and probably rising, you will raise some hackles. And, perhaps it’s inevitable that when you identify the causes of this public health crisis, the identified causes will push back.

The causes in this case involve no “bad guys,” no malice, and no ill intent, however. Rather, we might invoke a confluence of predictably unfortunate happenstance. The findings of large clinical trials make headlines. Headlines are, traditionally, designed for maximal titillation, meaning they are over-simplified and over-generalized as they were in this particular case. And, alas, in the case of hormone replacement, the headlines stuck- with all subtlety lost. A cultural aversion to hormone replacement overtook patients and clinicians alike. We are simply reporting the unintended consequences.

Peers pushing back against our paper have no real cause to do so. We are not accusing anyone of anything other than the unintended, adverse effects of medicine-meets-media business as usual. We are not refuting the value of the Women's Health Initiative (WHI). Quite the contrary; our data are from the WHI. The WHI has not done harm- misapplication of the WHI findings has done harm

We are certainly not saying that every woman with a hysterectomy should take estrogen. Our argument is exactly against the oversimplification of one-size-fits-all approaches. Headlines invite just such dumbing down- and our very point is that we need to get past the headlines to the relevant nuances. Good clinical care is not well informed by aversions or knee-jerk reactions. It is well informed only by the thoughtful application of the best possible information to a given individual patient’s circumstance.

In all of the commentary I have found, I see only one consistent challenge to our paper: it’s based on a mathematical model and the assumptions are uncertain. Perhaps, but consider this: evidence-based medicine, in its entirety, involves extrapolating the results of the best research to the care of patients. That, of course, is far less robust than a formal attempt to link the two in a mathematical model- it really is just informed observation. Evidence-based medicine comes down to this: “a clinical trial suggests a benefit from X in some people, and it seems to me that you, my patient, are enough like those people to benefit from X as well- and on that basis, I recommend/prescribe X for you.”

Make no mistake, that’s exactly what evidence-based medicine is: the application of results in one group (the trial participants) to all patients in the real world who seem to resemble that group. Examining this issue is not a seat-of-the-pants exercise in my case; I have published a textbook on the subject.

Which brings us back to estrogen. My colleagues and I, including Dr. Philip Sarrel, simply took the published results of the estrogen-versus-placebo branch of the WHI study conducted among women who had undergone hysterectomy, and asked and answered this question: if these results pertain to all women in the U.S. who meet the description of women in the trial, what would it mean? What it would mean is tens of thousands of premature deaths over a decade, just as we reported.

Peers have no business challenging the application of clinical trial data to the world at large in this one instance just because they don’t like the implications. If clinical trial data do not pertain to the world at large, then why on earth do we waste time (and fortunes of money) doing clinical trials in the first place? If what happens in the WHI stays in the WHI; if it only pertains to women in the trial- then someone owes the taxpayers an explanation for a boondoggle to the tune of almost half a billion dollars.

But that’s not the case. Clearly, the intent from the start, was to generate data in this huge clinical trial with real-world application. Clearly, the intent from the start was to extrapolate the WHI findings to all other women like those in the trial. That’s exactly what we did, merely adding the rigor of a cautious mathematical model.

If our very straightforward model translating the results of a clinical trial to the real-world population corresponding to the trial participants is really questionable, then it follows that so is everything about evidence-based medicine. Our peers simply cannot have their evidence-based cake and eat it, too.

My colleagues and I stand confidently, if unhappily, behind our conclusion that “estrogen aversion” has killed tens of thousands prematurely, and may do much worse if we don’t start approaching hormone replacement as the subtle, individualized clinical challenge it deserves to be. If there really is a problem with this assessment of estrogen, we have a much bigger problem to confront as well: there may be no such thing as reliably evidence-based medicine. Or maybe we just look the other way when the evidence is telling us something we don’t want to hear.

-fin

Dr. David L. Katz; https://www.davidkatzmd.com/

www.turnthetidefoundation.org

https://www.facebook.com/pages/Dr-David-L-Katz/114690721876253
https://twitter.com/DrDavidKatz
https://www.dhirubhai.net/pub/david-l-katz-md-mph/7/866/479/

Zhenxi Zhang

Scientist III at Labcorp Women's Health

11 年

The latest Time magazine has a story on the same topic (Aug. 5 issue, page 12). I agree that one-size-fits-all treatment is not possible for this kind of therapy that requires careful monitoring.

回复
Lisa Mahaffey,MSW

Writer: The Flip Side of Beauty and the Beast: A journey through life and love; on parenting and relationships

11 年

David L. Katz, MD, MPH Re the benefits of HRT for older women: researchers need to do research on the benefits of women staying on HRT(combination) forever. Specifically, on the benefits of never stopping HRT: studies on women who are on hormones(or birth control pills) and continue to take HRT into their 50's, 60's... It seems most studies on HRT are done on women who have stopped producing female hormones, and then much later get on HRT. These studies point towards this being risky. I have not seen any studies on the women who stay on hormones, and that part of their endocrine system has not shut down. This seems to be the problem: once your endocrine system shuts down, re female hormones, it may be risky to start HRT later. Doctors don' seem to have a clue. I was on birth control pills, felt great and was very healthy, and decided to stay on HRT(combination) as I started pre- menopause; and maybe forever. My doctors sound like they have never heard of that and wanted me to get off. The only studies they have seen are of women who have already gone through menopause, or are pre-menopausal, or had hysterectomy... I would love to see studies of us women who have simply stayed on HRT. I feel great, and am very healthy: am not experiencing all the common problems of menopause and aging women. So, would it be healthier for women to get on HRT during pre-menopause, if they are not already on HRT? ; Before their endocrine system re female hormones shuts down?

Sabrina D. Whiteman

Yale Administrative Staff

11 年

So I elected to have a hysterectomy at the end of this past year. No regrets whatsoever. Best thing to happen to me if you can imagine that. Lots of freedom from severe anemia and related issues. After years of suffering it was the right thing to do. However I kept one ovary (lost one to ovarian cancer many years ago) assuming that I am out of the woods in terms of needing any kind of hormone therapy right now. I am no where near the onset of menopause but I am assuming that I would need some sort of hormone intervention at THAT point, right?

回复

Thank you. I have been looking everywhere for an objective Point-of-View on this very subject. Now I can contnue with my estrogen without the fear.

要查看或添加评论,请登录

David L. Katz, MD, MPH的更多文章

  • Why Obesity is (still) Not a Disease

    Why Obesity is (still) Not a Disease

    Some of you- my contemporaries (and your parents)- may recall an episode of the original Star Trek that went something…

    31 条评论
  • The Better Assessment of Dietary Intake, Now

    The Better Assessment of Dietary Intake, Now

    A recent article in Science, citing a recent study in Nature Food, contends that we need a new and better way to…

    7 条评论
  • Ultra-Processed Foods: My Verdict

    Ultra-Processed Foods: My Verdict

    Guilty, as charged, in case you are quite short on time. If you have a minute, or ten, by all means- please read on.

    15 条评论
  • Of Blue Zones and Bull…Dozers

    Of Blue Zones and Bull…Dozers

    Since first learning of the Blue Zones over a decade ago, I have held them up as the most luminous, decisive…

    17 条评论
  • Correlation Isn’t Causation, Except When It Is

    Correlation Isn’t Causation, Except When It Is

    In the world at large- a clickbait, deepfake, soundbite world- nuance is everywhere on the ropes. We seek our answers…

    11 条评论
  • Food as Medicine: The Case for Measuring What We Intend to Manage

    Food as Medicine: The Case for Measuring What We Intend to Manage

    The Food-as-Medicine movement - a movement I applaud, in which I am involved, and arguably to which my whole career has…

    11 条评论
  • Nutrition Research, Olive Oil, and The Case for More 'And,' Less 'Or'

    Nutrition Research, Olive Oil, and The Case for More 'And,' Less 'Or'

    After some 40 years devoted to the science (and art) of applying nutrition to the promotion of human health, I hold…

    16 条评论
  • The Many Flavors of Optimal Nutrition

    The Many Flavors of Optimal Nutrition

    Some years ago, I wrote a commissioned article for a peer-reviewed compendium, entitled “Can We Say What Diet is Best…

    5 条评论
  • An Anti-Diet Antidote

    An Anti-Diet Antidote

    The “anti-diet” movement, we are told- specifically by The Washington Post and The Examination- began with good…

    22 条评论
  • Food as Medicine, and the Pseudo-Sophistication of Doubt

    Food as Medicine, and the Pseudo-Sophistication of Doubt

    A colleague and I recently had the opportunity to “pitch” what we do, what our company offers, to a convened group of…

    13 条评论

社区洞察

其他会员也浏览了